Vimarsana
Biggest News Aggregation in the World

Disease Volume News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disease Volume. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disease Volume Today - Breaking & Trending Today

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription - Vimarsana News

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription

Compared to Black and Asian people, white and Hispanic people with Alzheimer's disease and related dementias were most likely to be diagnosed with symptoms like depression and agitation, according to a new study from the USC Schaeffer Center for Health Policy & Economics.

Multimodal intervention approach shows promise in managing and reversing cognitive impairment - Vimarsana News

Multimodal intervention approach shows promise in managing and reversing cognitive impairment

Dr. Heather Sandison, a leading expert in Alzheimer's Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer's Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline.

Factors in Selecting Therapy for Patients With Metastatic Hormone-Sensitive Prostate Cancer - Vimarsana News

Factors in Selecting Therapy for Patients With Metastatic Hormone-Sensitive Prostate Cancer

A focused review of patient and disease factors that inform selection of therapy for patients with metastatic hormone-sensitive prostate cancer.

New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone- - Vimarsana News

New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-

New post hoc subgroup analyses from Phase III ARASENS trial in mHSPC show that NUBEQA plus androgen deprivation therapy (ADT) and docetaxel compared to ADT and docetaxel increased overall survival (OS) in specific subgroups with various types of metastatic disease burden and risk1Incidence of adverse events was simi...

Precision Medicine Approach Reverses Early-Stage Dementia - Vimarsana News

Precision Medicine Approach Reverses Early-Stage Dementia

/PRNewswire/ -- Amid repeated failures of drug trials for Alzheimer's disease, a small pilot study using a precision medicine approach has reported the first...